Cargando…
Cost-Effectiveness of Routine Third Trimester Ultrasound Screening for Fetal Growth Restriction Compared to Care as Usual in Low-Risk Pregnancies: A Pragmatic Nationwide Stepped-Wedge Cluster-Randomized Trial in The Netherlands (the IRIS Study)
Routine third trimester ultrasonography is increasingly used to screen for fetal growth restriction. However, evidence regarding its cost-effectiveness is lacking. We aimed to evaluate the cost-effectiveness of routine third trimester ultrasonography to reduce adverse perinatal outcomes compared to...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955489/ https://www.ncbi.nlm.nih.gov/pubmed/35329004 http://dx.doi.org/10.3390/ijerph19063312 |
_version_ | 1784676348460007424 |
---|---|
author | Henrichs, Jens de Jonge, Ank Westerneng, Myrte Verfaille, Viki Franx, Arie van der Horst, Henriëtte E. Bosmans, Judith E. |
author_facet | Henrichs, Jens de Jonge, Ank Westerneng, Myrte Verfaille, Viki Franx, Arie van der Horst, Henriëtte E. Bosmans, Judith E. |
author_sort | Henrichs, Jens |
collection | PubMed |
description | Routine third trimester ultrasonography is increasingly used to screen for fetal growth restriction. However, evidence regarding its cost-effectiveness is lacking. We aimed to evaluate the cost-effectiveness of routine third trimester ultrasonography to reduce adverse perinatal outcomes compared to usual care (selective ultrasonography). An economic evaluation alongside a stepped-wedge cluster-randomized trial was conducted. Via 60 midwifery practices 12,974 Dutch women aged ≥16 years with low-risk pregnancies were enrolled at 22.8 (SD = 2.4) weeks’ gestation. All practices provided usual care. At 3, 7, and 10 months a third of the practices were randomized to the intervention strategy providing routine ultrasonography at 28–30 and 34–36 weeks’ gestation and usual care. The primary clinical outcome was a dichotomous composite measure of 12 severe adverse perinatal outcomes (SAPO) up to one week postpartum. Information on perinatal care and societal costs was derived from Netherlands Perinatal Registry, hospital records and a survey. Cost-effectiveness analyses revealed no significant differences in SAPO and healthcare and societal costs between the intervention strategy (n = 7026) and usual care (n = 5948). Cost-effectiveness acceptability curves showed that the probability of cost-effectiveness was never higher than 0.6 for all possible ceiling ratios. Adding routine third trimester ultrasonography to usual care is not cost-effective in reducing SAPO. |
format | Online Article Text |
id | pubmed-8955489 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89554892022-03-26 Cost-Effectiveness of Routine Third Trimester Ultrasound Screening for Fetal Growth Restriction Compared to Care as Usual in Low-Risk Pregnancies: A Pragmatic Nationwide Stepped-Wedge Cluster-Randomized Trial in The Netherlands (the IRIS Study) Henrichs, Jens de Jonge, Ank Westerneng, Myrte Verfaille, Viki Franx, Arie van der Horst, Henriëtte E. Bosmans, Judith E. Int J Environ Res Public Health Article Routine third trimester ultrasonography is increasingly used to screen for fetal growth restriction. However, evidence regarding its cost-effectiveness is lacking. We aimed to evaluate the cost-effectiveness of routine third trimester ultrasonography to reduce adverse perinatal outcomes compared to usual care (selective ultrasonography). An economic evaluation alongside a stepped-wedge cluster-randomized trial was conducted. Via 60 midwifery practices 12,974 Dutch women aged ≥16 years with low-risk pregnancies were enrolled at 22.8 (SD = 2.4) weeks’ gestation. All practices provided usual care. At 3, 7, and 10 months a third of the practices were randomized to the intervention strategy providing routine ultrasonography at 28–30 and 34–36 weeks’ gestation and usual care. The primary clinical outcome was a dichotomous composite measure of 12 severe adverse perinatal outcomes (SAPO) up to one week postpartum. Information on perinatal care and societal costs was derived from Netherlands Perinatal Registry, hospital records and a survey. Cost-effectiveness analyses revealed no significant differences in SAPO and healthcare and societal costs between the intervention strategy (n = 7026) and usual care (n = 5948). Cost-effectiveness acceptability curves showed that the probability of cost-effectiveness was never higher than 0.6 for all possible ceiling ratios. Adding routine third trimester ultrasonography to usual care is not cost-effective in reducing SAPO. MDPI 2022-03-11 /pmc/articles/PMC8955489/ /pubmed/35329004 http://dx.doi.org/10.3390/ijerph19063312 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Henrichs, Jens de Jonge, Ank Westerneng, Myrte Verfaille, Viki Franx, Arie van der Horst, Henriëtte E. Bosmans, Judith E. Cost-Effectiveness of Routine Third Trimester Ultrasound Screening for Fetal Growth Restriction Compared to Care as Usual in Low-Risk Pregnancies: A Pragmatic Nationwide Stepped-Wedge Cluster-Randomized Trial in The Netherlands (the IRIS Study) |
title | Cost-Effectiveness of Routine Third Trimester Ultrasound Screening for Fetal Growth Restriction Compared to Care as Usual in Low-Risk Pregnancies: A Pragmatic Nationwide Stepped-Wedge Cluster-Randomized Trial in The Netherlands (the IRIS Study) |
title_full | Cost-Effectiveness of Routine Third Trimester Ultrasound Screening for Fetal Growth Restriction Compared to Care as Usual in Low-Risk Pregnancies: A Pragmatic Nationwide Stepped-Wedge Cluster-Randomized Trial in The Netherlands (the IRIS Study) |
title_fullStr | Cost-Effectiveness of Routine Third Trimester Ultrasound Screening for Fetal Growth Restriction Compared to Care as Usual in Low-Risk Pregnancies: A Pragmatic Nationwide Stepped-Wedge Cluster-Randomized Trial in The Netherlands (the IRIS Study) |
title_full_unstemmed | Cost-Effectiveness of Routine Third Trimester Ultrasound Screening for Fetal Growth Restriction Compared to Care as Usual in Low-Risk Pregnancies: A Pragmatic Nationwide Stepped-Wedge Cluster-Randomized Trial in The Netherlands (the IRIS Study) |
title_short | Cost-Effectiveness of Routine Third Trimester Ultrasound Screening for Fetal Growth Restriction Compared to Care as Usual in Low-Risk Pregnancies: A Pragmatic Nationwide Stepped-Wedge Cluster-Randomized Trial in The Netherlands (the IRIS Study) |
title_sort | cost-effectiveness of routine third trimester ultrasound screening for fetal growth restriction compared to care as usual in low-risk pregnancies: a pragmatic nationwide stepped-wedge cluster-randomized trial in the netherlands (the iris study) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955489/ https://www.ncbi.nlm.nih.gov/pubmed/35329004 http://dx.doi.org/10.3390/ijerph19063312 |
work_keys_str_mv | AT henrichsjens costeffectivenessofroutinethirdtrimesterultrasoundscreeningforfetalgrowthrestrictioncomparedtocareasusualinlowriskpregnanciesapragmaticnationwidesteppedwedgeclusterrandomizedtrialinthenetherlandstheirisstudy AT dejongeank costeffectivenessofroutinethirdtrimesterultrasoundscreeningforfetalgrowthrestrictioncomparedtocareasusualinlowriskpregnanciesapragmaticnationwidesteppedwedgeclusterrandomizedtrialinthenetherlandstheirisstudy AT westernengmyrte costeffectivenessofroutinethirdtrimesterultrasoundscreeningforfetalgrowthrestrictioncomparedtocareasusualinlowriskpregnanciesapragmaticnationwidesteppedwedgeclusterrandomizedtrialinthenetherlandstheirisstudy AT verfailleviki costeffectivenessofroutinethirdtrimesterultrasoundscreeningforfetalgrowthrestrictioncomparedtocareasusualinlowriskpregnanciesapragmaticnationwidesteppedwedgeclusterrandomizedtrialinthenetherlandstheirisstudy AT franxarie costeffectivenessofroutinethirdtrimesterultrasoundscreeningforfetalgrowthrestrictioncomparedtocareasusualinlowriskpregnanciesapragmaticnationwidesteppedwedgeclusterrandomizedtrialinthenetherlandstheirisstudy AT vanderhorsthenriettee costeffectivenessofroutinethirdtrimesterultrasoundscreeningforfetalgrowthrestrictioncomparedtocareasusualinlowriskpregnanciesapragmaticnationwidesteppedwedgeclusterrandomizedtrialinthenetherlandstheirisstudy AT bosmansjudithe costeffectivenessofroutinethirdtrimesterultrasoundscreeningforfetalgrowthrestrictioncomparedtocareasusualinlowriskpregnanciesapragmaticnationwidesteppedwedgeclusterrandomizedtrialinthenetherlandstheirisstudy AT costeffectivenessofroutinethirdtrimesterultrasoundscreeningforfetalgrowthrestrictioncomparedtocareasusualinlowriskpregnanciesapragmaticnationwidesteppedwedgeclusterrandomizedtrialinthenetherlandstheirisstudy |